Home > Insider Trading > Filing (0001209191-17-015557)

Filing Details

Accession Number:: 0001209191-17-015557
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-02-28 20:46:38
Reporting Period:: 2017-02-24

Filing Date:: 2017-02-28
Accepted Time:: 2017-02-28 20:46:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
353569	Quidel Corp	QDEL	In Vitro & In Vivo Diagnostic Substances (2835)	942573850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1406652	C Douglas Bryant	12544 High Bluff Drive, Suite 200 San Diego CA 92130	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-02-24	44,000	$8.50	322,958	No	4	M	Direct
Common Stock	Disposition	2017-02-24	44,000	$21.11	278,958	No	4	S	Direct
Common Stock	Acquisiton	2017-02-24	1,061	$0.00	280,019	No	4	A	Direct
Common Stock	Disposition	2017-02-24	398	$21.15	279,621	No	4	F	Direct
Common Stock	Acquisiton	2017-02-25	1,097	$0.00	280,718	No	4	A	Direct
Common Stock	Disposition	2017-02-25	412	$21.15	280,306	No	4	F	Direct
Common Stock	Acquisiton	2017-02-27	17,212	$8.50	297,518	No	4	M	Direct
Common Stock	Acquisiton	2017-02-27	18,788	$12.36	316,306	No	4	M	Direct
Common Stock	Disposition	2017-02-27	36,000	$21.82	280,306	No	4	S	Direct
Common Stock	Acquisiton	2017-02-28	26,920	$12.36	307,226	No	4	M	Direct
Common Stock	Disposition	2017-02-28	26,920	$21.30	280,306	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	A	Direct
No	4	F	Direct
No	4	A	Direct
No	4	F	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Options	Disposition	2017-02-24	44,000	$0.00	44,000	$8.50
Common Stock	Non-Qualified Stock Options	Disposition	2017-02-27	17,212	$0.00	17,212	$8.50
Common Stock	Non-Qualified Stock Options	Disposition	2017-02-27	18,788	$0.00	18,788	$12.36
Common Stock	Non-Qualified Stock Options	Disposition	2017-02-28	26,920	$0.00	26,920	$12.36

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
17,212	2013-04-10	2019-04-10	No	4	M	Direct
0	2013-04-10	2019-04-10	No	4	M	Direct
681,212	2013-02-02	2019-02-02	No	4	M	Direct
654,292	2013-02-02	2019-02-02	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a pre-established 10b5-1 trading plan.
The amount of securities beneficially owned following this transaction include an additional 1,113 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.
The weighted average sale price for these transactions was $21.1065 per share, with a range of $20.80 to $21.47 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
Reflects release of restricted stock units that were previously reported on Form 4.
Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
The weighted average sale price for these transactions was $21.815 per share, with a range of $21.24 to $22.14 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
The weighted average sale price for these transactions was $21.296 per share, with a range of $20.96 to $21.77 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.